MetLife (MET) Stock Price, News & Analysis

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

Key Stats

• Today's Range: $77.71 to $78.53
• 50-Day Range: $76.22 to $81.02
• 52-Week Range: $65.21 to $89.05
• Volume: 2.23 million shs
• Average Volume: 2.52 million shs
• Market Capitalization: $52.24 billion
• P/E Ratio: 12.65
• Dividend Yield: 2.92%
• Price Target: $96.09
• Consensus Rating: Moderate Buy

MetLife Stock Analysis - MarketRank™

MetLife scored higher than 100% of companies evaluated by MarketBeat, and ranked 4th out of 921 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

MetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

MetLife has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 9.53%

Earnings Growth

Earnings for MetLife are expected to grow by 9.53% in the coming year, from $9.65 to $10.57 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of MetLife is 12.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.77.

Price to Earnings Ratio vs. Sector

The P/E ratio of MetLife is 12.65, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.06.

Price to Earnings Growth Ratio

MetLife has a PEG Ratio of 0.64. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

MetLife has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.26% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently decreased by 10.97%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

MetLife pays a meaningful dividend of 2.89%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MetLife has been increasing its dividend for 12 years.

Dividend Coverage

The dividend payout ratio of MetLife is 36.91%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, MetLife will have a dividend payout ratio of 21.48% next year. This indicates that MetLife will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.0 / 5
• Environmental Score: -0.75

Percentage of Shares Shorted

1.26% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently decreased by 10.97%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.23

News Sentiment

MetLife has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for MetLife this week, compared to 26 articles on an average week.

Search Interest

29 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 480% compared to the previous 30 days.

MarketBeat Follows

Only 10 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MetLife insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.35% of the stock of MetLife is held by insiders.

Percentage Held by Institutions

94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MET Stock Analysis - Frequently Asked Questions

How have MET shares performed this year?

MetLife's stock was trading at $81.88 at the beginning of 2025. Since then, MET stock has decreased by 5.0% and is now trading at $77.8210.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) issued its earnings results on Wednesday, April, 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by $0.04. MetLife's revenue for the quarter was up 15.6% on a year-over-year basis.
Read the conference call transcript.

Is MetLife doing a stock buyback?

MetLife's board initiated a stock buyback plan on Wednesday, April 30th 2025, which authorizes the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 5.9% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its shares are undervalued.

Does MetLife have any subsidiaries?

MetLife subsidiaries include Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more.

Who are MetLife's major shareholders?

MetLife's top institutional shareholders include Swedbank AB (0.47%), Assenagon Asset Management S.A., Aberdeen Group plc (0.13%) and Truist Financial Corp (0.09%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends.

How do I buy shares of MetLife?

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

• Last Earnings: 4/30/2025
• Record date for 6/10 Dividend: 5/06/2025
• Ex-Dividend for 6/10 Dividend: 5/06/2025
• Dividend Payable: 6/10/2025
• Today: 7/24/2025
• Record date for 9/9 Dividend: 8/05/2025
• Ex-Dividend for 9/9 Dividend: 8/05/2025
• Next Earnings (Confirmed): 8/06/2025
• Dividend Payable: 9/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: INS - MULTI LINE
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:MET
• CIK: 1099219
• Web: www.metlife.com
• Phone: (212) 578-9500
• Fax: 212-578-3320
• Employees: 45,000
• Year Founded: 1868

Price Target and Rating

• Average Price Target for MetLife: $96.09
• High Price Target: $99.00
• Low Price Target: $94.00
• Potential Upside/Downside: +23.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.92
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.15
• Trailing P/E Ratio: 12.65
• Forward P/E Ratio: 8.06
• P/E Growth: 0.64
• Net Income: $4.43 billion
• Net Margins: 6.08%
• Pretax Margin: 8.07%
• Return on Equity: 20.89%
• Return on Assets: 0.87%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $70.99 billion
• Price / Sales: 0.74
• Cash Flow: $7.13 per share
• Price / Cash Flow: 10.92
• Book Value: $40.01 per share
• Price / Book: 1.95

Miscellaneous

• Outstanding Shares: 671,300,000
• Free Float: 668,948,000
• Market Cap: $52.24 billion
• Optionable: Optionable
• Beta: 0.85